Prevalence of hepatitis B virus and associated risk factors among adults patients at Dessie referral and Kemise general hospitals in northeastern Ethiopia.
associated risk factors
hepatitis B virus
northeastern Ethiopia
prevalence
Journal
Health science reports
ISSN: 2398-8835
Titre abrégé: Health Sci Rep
Pays: United States
ID NLM: 101728855
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
20
09
2021
revised:
01
04
2022
accepted:
26
04
2022
entrez:
27
5
2022
pubmed:
28
5
2022
medline:
28
5
2022
Statut:
epublish
Résumé
Hepatitis is an inflammation of the liver that can reason a variety of health problems and can be fatal. According to the most recent estimates of the Global Burden of Disease study and WHO, viral hepatitis is accountable for around 1.34 million deaths yearly, which is comparable to the yearly number of deaths from HIV/AIDS (1.3 million), malaria (0.9 million), and tuberculosis (1.3 million). This study aimed to assess the prevalence of the Hepatitis B virus and associated risk factors among adults patients at Dessie Referral and Kemise General Hospitals. The source for the data on Hepatitis B virus (HBV) was all adults aged≥18 years that were admitted and tested for HBV from September 2020 to February 2021 were included in the study. A total of 1283 adults were admitted out of which, 1080 adults have completed measurements and had been taken into consideration for this examination, and others had been excluded from the examination because of exclusion criteria. To meet our objective descriptive statistics, the In this study, a total of 1080 adults were included out of which 631 (58.4%) female and 449 (41.6%) were male with a mean age of 34(SD ± The prevalence of HBV in this study is 27.4%. The results of this study showed that age, male, history of hospitalization, family history of HBV, and jaundice were significant risk factors for Hepatitis B virus.
Sections du résumé
Background and Aims
UNASSIGNED
Hepatitis is an inflammation of the liver that can reason a variety of health problems and can be fatal. According to the most recent estimates of the Global Burden of Disease study and WHO, viral hepatitis is accountable for around 1.34 million deaths yearly, which is comparable to the yearly number of deaths from HIV/AIDS (1.3 million), malaria (0.9 million), and tuberculosis (1.3 million). This study aimed to assess the prevalence of the Hepatitis B virus and associated risk factors among adults patients at Dessie Referral and Kemise General Hospitals.
Methods
UNASSIGNED
The source for the data on Hepatitis B virus (HBV) was all adults aged≥18 years that were admitted and tested for HBV from September 2020 to February 2021 were included in the study. A total of 1283 adults were admitted out of which, 1080 adults have completed measurements and had been taken into consideration for this examination, and others had been excluded from the examination because of exclusion criteria. To meet our objective descriptive statistics, the
Results
UNASSIGNED
In this study, a total of 1080 adults were included out of which 631 (58.4%) female and 449 (41.6%) were male with a mean age of 34(SD ±
Conclusion
UNASSIGNED
The prevalence of HBV in this study is 27.4%. The results of this study showed that age, male, history of hospitalization, family history of HBV, and jaundice were significant risk factors for Hepatitis B virus.
Identifiants
pubmed: 35620544
doi: 10.1002/hsr2.659
pii: HSR2659
pmc: PMC9125169
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e659Informations de copyright
© 2022 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Lancet. 2015 Oct 17;386(10003):1546-55
pubmed: 26231459
Health Sci Rep. 2022 May 22;5(3):e659
pubmed: 35620544
Virol J. 2013 May 30;10:171
pubmed: 23721493
J Prim Care Community Health. 2021 Jan-Dec;12:2150132721993628
pubmed: 33565356
PLoS One. 2016 Nov 29;11(11):e0166936
pubmed: 27898721
BMC Public Health. 2013 Jan 18;13:50
pubmed: 23331910
J Pregnancy. 2018 Aug 05;2018:8435910
pubmed: 30174956
Int J Gen Med. 2020 Jun 22;13:323-332
pubmed: 32606897
BMC Public Health. 2016 Aug 11;16(1):769
pubmed: 27514515
Lancet Gastroenterol Hepatol. 2017 Dec;2(12):900-909
pubmed: 29132759
BMC Infect Dis. 2016 Dec 19;16(1):761
pubmed: 27993129
PLoS One. 2020 May 7;15(5):e0232653
pubmed: 32379803
PLoS One. 2014 Feb 03;9(2):e87599
pubmed: 24498341
Virol J. 2015 Dec 02;12:204
pubmed: 26626263
AIDS Res Ther. 2016 Feb 04;13:6
pubmed: 26855663
PLoS Med. 2020 Apr 21;17(4):e1003068
pubmed: 32315297
BMJ Open. 2020 Jun 3;10(6):e033043
pubmed: 32499255
Hum Vaccin Immunother. 2021 Jun 3;17(6):1818-1824
pubmed: 33606606
BMC Public Health. 2013 Aug 07;13:727
pubmed: 23919752
Int J Med Sci. 2011;8(4):321-31
pubmed: 21611114
BMJ Open. 2017 Apr 3;7(4):e014947
pubmed: 28373257
PLoS Negl Trop Dis. 2017 Oct 5;11(10):e0005842
pubmed: 28981505
Hepat Res Treat. 2016;2016:9290163
pubmed: 26904281